Idiopathic intracranial hypertension associated with SARS-CoV-2 infection in an adult male patient: a case report and review of the literature
ConclusionIdiopathic intracranial hypertension (IIH) may occur in association with SARS-CoV-2 infection and should be considered when making a differential diagnosis for headache and blurring of vision. COVID-19 may play a role in the development of intracranial hypertension, even in the absence of known risk factors. Early diagnosis and treatment of IIH has paramount importance to prevent vision loss and other morbidities. (Source: Journal of Medical Case Reports)
Source: Journal of Medical Case Reports - April 25, 2024 Category: General Medicine Source Type: research
The burden of headache disorders in the adult general population of the Kingdom of Saudi Arabia: estimates from a cross-sectional population-based study including a health-care needs assessment
ConclusionA very high symptom burden is associated with a commensurately high burden of impaired participation. The economic cost appears to be enormous. Over a third of the adult population are revealed to require headache-related health care on the basis of being likely to benefit, demanding highly efficient organization of care. (Source: The Journal of Headache and Pain)
Source: The Journal of Headache and Pain - April 25, 2024 Category: Neurology Source Type: research
Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study
ConclusionThis real-world evidence study demonstrated high overall satisfaction with the effectiveness of eptinezumab treatment for CM among most patients and their physicians. (Source: The Journal of Headache and Pain)
Source: The Journal of Headache and Pain - April 25, 2024 Category: Neurology Source Type: research
Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults
Expert Rev Neurother. 2024 Apr 24:1-10. doi: 10.1080/14737175.2024.2342446. Online ahead of print.ABSTRACTINTRODUCTION: Although the landscape of migraine symptomatic treatment has been enriched by novel effective drugs, it is mandatory to critically reappraise older molecules to ascertain whether they could still represent reliable alternatives in specific endophenotypes of patients or migraine attacks. Among these, dihydroergotamine (DHE) nasal spray has been shown to be effective and is characterized by greater tolerability and manageability than the parenteral DHE formulation.AREAS COVERED: In this narrative review, th...
Source: Expert Review of Neurotherapeutics - April 24, 2024 Category: Neurology Authors: Marcello Silvestro Ilaria Orologio Alessandro Tessitore Francesca Trojsi Gioacchino Tedeschi Antonio Russo Source Type: research
